Women and epilepsy;Spezifische aspekte der beratung und behandlung von frauen mit epilepsie

Nervenheilkunde

Volumn 20, Issue 9, 2001, Pages 499-505

  Beyenburg, S ^a   Bauer, J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Catamenial seizures; Epilepsy; Pharmakotherapy; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; ENZYME INDUCING AGENT; PROGESTERONE; VITAMIN K GROUP;

ANOVULATION; ANTICONVULSANT ACTIVITY; BLEEDING; BREAST FEEDING; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; ECHOGRAPHY; EPILEPSY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENSTRUAL CYCLE; PATIENT COUNSELING; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SEIZURE; TEMPORAL LOBE EPILEPSY; TERATOGENICITY; WITHDRAWAL SYNDROME;

EID: 0035181194     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Antenatal drugs affecting vitamin K status of the fetus and the newborn
2. Gynäkologisch relevante aspekte in der behandlung von frauen mit epilepsie
3. Catamenial epilepsy and menopause
4. Polyzystisches ovarien-syndrom und epilepsie: Eine aktuelle bestandsaufnahme
5. Katameniale anfälle: Eine analyse
6. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: A prospective study
7. The effect of a synthetic GnRH analogue on catamenial epilepsy: A study in ten patients
8. The impact of epilepsy surgery on serum sex hormones and menstrual cycles in female patients
9. Anticonvulsants and breast feeding. A critical review
10. Prevention of neuraltube defects with folic acid in China
11. Neuroactive steroids and seizure susceptibility
12. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency
13. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy
14. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
15. Epileptogenic activity of folic acid after drug induced SLE (folic acid and epilepsy)
16. Frauen und epilepsie
17. On the association between valproate and polycystic ovary syndrome
18. The effect of menopause and perimenopause on the course of epilepsy
19. Folic acid and antagonists during pregnancy and the risk of birth defects
20. Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids, and emotions
21. Psychoneuroendocrine aspects of temporolimbic epilepsy. Part II. Epilepsy and reproductive steroids
22. Obstetric outcome in women with epilepsy
23. The teratogenicity of anticonvulsant drugs
24. Congenital malformations due to antiepileptic drugs
25. Prevention of neural tube defects: Results of the Medical Research Council vitamin study
26. Treatment of epilepsy in pregnancy
27. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: A pharmaceutical company commitment
28. Antiepileptic drug regimens and major congenital abnormalities in the offspring
29. Epilepsien
30. Neural tube defects recurrence after "partial" vitamin supplementation
31. Pregnancy and epilepsy
32. Recommendations for the management and care of pregnant women with epilepsy
33. Management issues for women with epilepsy. A review of the literature